Condition: Acute Lymphoblastic Leukemia · Lymphoblastic Lymphoma · Young Adult Cancer · Sponsor: Resonance, Inc.
Despite advances in cancer treatment, significant disparities in outcomes persist between high-income countries (HICs) and low-and middle-income countries (LMICs). Around 80% of children with cancer live in LMICs, where they face challenges such as delayed diagnosis, misdiagnosis, comorbidities, distance to treatment, financial barriers, and limited access to risk-adapted therapies. Acute lymphoblastic leukemia(ALL)/lymphoblastic lymphoma(LBL), for example, is one of the greatest success stories in pediatric oncology, however, such improvements are not evenly distributed worldwide, and the outcomes for leukemia patients are poorer in LMICs compared to HICs, primarily due to reduced access to quality healthcare. This study aims to assess cancer treatment outcomes in LMICs, focusing on acute lymphoblastic leukemia/lymphoblastic lymphoma. The findings will inform future studies to implement evidence-based interventions that improve care quality and reduce treatment failures through targeted strategies.
This description comes directly from the study's public registry record.
Gabriela Villanueva, MD. · +1-901-205-9518 · gabriela.villanueva@resonancehealth.org
Always discuss trial participation with your own doctor first.
| Yeolyan Center for Cancer and Blood Disorders | Yerevan, Armenia | Recruiting |
| Fundación Ayúdame a Vivir | El Salvador, El Salvador, El Salvador | Not Yet Recruiting |
| Unidad Nacional de Oncología Pediátrica (UNOP) | Guatemala City, Guatemala | Recruiting |
| Hospital Mario Catarino Rivas | San Pedro Sula, Cortés Department, Honduras | Not Yet Recruiting |
| Hospital Escuela | Tegucigalpa, Distrito Central, Honduras | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07246213